A future sequencing study of the entire PPARGC1A locus in large ovarian and breast cancer cohorts, particularly in cancer patients with family history, is warranted to further validate our finding of PPARGC1A as a BRCA1/2 genetic modifier. Here, PPARGC1A is linked to breast carcinoma.